glp-1 drugs and cancer Glucagon-like peptide 1 receptor agonists risk: advancing precision medicine through mechanistic understanding and clinical evidence | Biomarker Research Are GLP-1 Drugs Are Next

Glutathione IV therapy might offer the revitalization you are seeking

Scientists & pharmacists had already had a new version of BPC-157 in development called Pentadeca Arginate (PDA)

Don't expect dramatic regrowth

found that reduced CSF PLP concentrations may be a more sensitive indicator of vitamin B6-dependent epilepsy, especially vitamin B6-dependent epilepsy caused by mutations in PLPBP [12]

Ascorbate may also play a key role in policing organelle to nucleus communication and signalling pathways

Interestingly, DPP4 is also able to promote T-cell proliferation independent from ADA binding or even its enzymatic activity (27)